Casandra
Casandra Test Code AR13793Version 1 (DRAFT)
Performing Lab
HER2/neu by Immunoassay, Serum
Also known as: HER2 QUANT
Clinical Use
Order TestUse
May be used to monitor metastatic breast cancer in patients. Use in conjunction with other clinical findings.
Special Instructions
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Limitations
Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.
Test Details
New York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
HER-2/neu
ProteinConcentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
LOINC Codes
Result Codes
- 42914-2
Result Turnaround Time
5-10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
Plain red or serum separator tube (SST)
Collection Instructions
Transfer 1 mL serum to an ARUP standard transport tube.
Storage Instructions
CRITICAL FROZEN.
Causes for Rejection
Hemolyzed or thawed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | Unacceptable |
| Frozen | Indefinitely |